MedPath

Effect of prophylactic administration of magnesium sulfate on cardiovascular changes during general anesthesia in Gynecologic laparoscopic surgery

Phase 2
Conditions
Effect of prophylactic administration of two doses of magnesium sulfate on cardiovascular changes during general anesthesia in Gynecologic laparoscopic surgery.
Magnesium deficiency
Registration Number
IRCT20190105042236N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
100
Inclusion Criteria

Patients ASA 1
Patients ASA 2
Women Laparoscopic Surgery
Outer uterus and endometriosis and diagnosis (infertility)
Maximum operating time is 150 minutes

Exclusion Criteria

High blood pressure
Sensitization to magnesium sulfate
Heart block
Emergency situation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of systolic blood pressure. Timepoint: before the induction of anesthesia as a base and after the anesthesia were measured and recorded after the finishing of the infused medication. These parameters were measured and recorded immediately before the pneumoperitoneum and 5, 10, 20, 30,40 minutes After pneumoperitoneum. Method of measurement: Barometer.;Change of heart rate. Timepoint: before the induction of anesthesia as a base and after the anesthesia were measured and recorded after the finishing of the infused medication. These parameters were measured and recorded immediately before the pneumoperitoneum and 5, 10, 20, 30,40 minutes After pneumoperitoneum. Method of measurement: Pulse oximeter.
Secondary Outcome Measures
NameTimeMethod
The amount of chills and vomiting. Timepoint: After the recovery. Method of measurement: Objective observation and question.
© Copyright 2025. All Rights Reserved by MedPath